Welcome to the ATTD 2023 Interactive Program
Session Description: This program reviews recently updated clinical practice guidelines on the use of RT-CGM in the management of type 2 diabetes. We will also present new data on the use of RT-CGM early in the course of care for type 2 diabetes. Additionally, we will examine how improving access for people with type 2 diabetes, on less intensive insulin regimens is positioned to impact utilization and adoption of RT-CGM in clinical practice. Hear from the experts regarding the ways to simplify the review of CGM data, specifically for type 2 diabetes, and steps that have been taken to integrate Dexcom Clarity data into electronic health records for more efficient clinical workflows.